Physician profile
Clint B Meyer
NPI 1215929609
$5,021.12
in general payments reported to CMS, 2019-2025
16 companies · $249 in 2025
The $249 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $703 · 2020: $337 · 2021: $1,111 · 2022: $851 · 2023: $1,063 · 2024: $708 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,020.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,020.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,718.50 | 2019-2025 | Precision 1, Precision7, Dailies |
| Eyevance Pharmaceuticals LLC | $706.10 | 2020-2022 | |
| Johnson & Johnson Vision Care, INC. | $674.25 | 2019-2024 | Acuvue |
| Bausch & Lomb Americas INC. | $540.23 | 2023-2025 | Infuse, Miebo, Xiidra |
| Coopervision INC. | $270.47 | 2021-2025 | Myday Contact Lens, Clariti Contact Lens |
| Abbvie INC. | $229.87 | 2022-2023 | |
| Sun Pharmaceutical Industries INC. | $199.80 | 2023-2024 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $162.30 | 2019-2021 | |
| Genentech USA, INC. | $122.16 | 2019 | |
| Optos, INC. | $100.51 | 2021 | |
| Novartis Pharmaceuticals Corporation | $87.07 | 2021-2023 | |
| Biotissue Holdings INC. | $65.31 | 2024 | |
| Glaukos Corporation | $60.20 | 2022 | |
| Allergan, INC. | $50.45 | 2022 | |
| Thea Pharma INC. | $18.67 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $15.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clint Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.